Talking of India, the country with the world’s second-largest population base, having high incidence rate of all major adult and pediatric diseases, is a huge potential market for all leading vaccine manufacturers. Several multinational companies consider India as the key market for vaccines with the National Immunization Program (NIP) gaining more popularity.
The country’s share in the global vaccine market is consistently growing and accounts for approximately 4% share in the global market. At present, exports have a major share (over 70%) in the Indian vaccine market. In the report, vaccine market has been classified based on 16 therapeutic categories and market for each has been forecasted till 2020. The report also covers advanced stage pipeline analysis of key players of this market which list down the vaccines already in Phase Ill trials.
In addition to this, analysts have studied the business dynamics of key players in the industry. A brief business overview with their product portfolio has been provided in the report. Moreover, our team has also analyzed each company’s strengths and weaknesses along with Its vaccine portfolio and pipeline that will help the reader to better position his/her company veils-;-veils competition. The report provides a thorough research and rational analysis of the current status ND expected position of the global vaccines market.
It facilitates the future forecasts on the total vaccines market, therapeutic categories and regional markets. Overall, the report contains key actionable Insights that will help the reader to gain a deeper knowledge of the Industry.
